George AuditoriumRhode Island HospitalThursday, October 31, 2013 9 a.m. - 12 p.m.
Steven Kunkel, PhD is the endowed professor of pathology research, head of the immunology program, and senior associate dean for research at the University of
Michigan Medical School.
His areas of research have centered on assessing molecular mechanisms of lung inflammation by investigating cytokine directed
cell-to-cell communication circuits. A significant amount of this work helped to launch and define the field of chemokine biology. In addition, he has been
involved in assessing epigenetic regulation of immune cell phenotypes that dictates the expression pattern of inflammatory mediators.
His studies in
cytokine and chemokine biology are internationally recognized and have provided a more clear understanding of how these proteins are regulated and
participate in the initiation, maintenance, and resolution of acute and chronic lung.
As the senior associate dean for research in the University of Michigan Medical School, he
oversees all basic and clinical research. In addition, he is the former chair of the Board of Scientific Counselors for the NIAID-NIH, a member of the
American Society for Clinical Investigation, and a fellow of the American Association for the Advancement of Science.
Jennifer Friedman, MD, PhD is a pediatrician who conducts global health research at Lifespan's Center for International Health Research.
addresses how parasitic diseases, particularly malaria and schistosomiasis (a worm infection of the liver and intestines) cause morbidity for pregnant
women and children. Previous research has addressed whether or not these infections are associated with malnutrition, anemia and cognitive impairment
among children. She has also researched more effective ways to treat these morbidities by studying how these parasites cause illness.
She is currently leading an NIH funded RCT evaluating the safety and efficacy of praziquantel given at 12-16 weeks gestation for the treatment of
schistosomiasis. That study, and a study that subsequently followed the infants, will address whether treatment decreases maternal anemia risk, increases
birth weight, and the long term effects of maternal treatment on infant nutritional status, anemia risk, and cognitive performance at 12 months of life.
Please note that the poster sessions and the young investigator awards are on hold for this year.